EGFR and breast cancer: Follow-up studies demonstrated that ST8SIA1 maintains stem cell phenotype in breast CSCs, and that GD3 synthases may be involved in gefitinib-resistance of epidermal growth factor receptor (EGFR)-positive breast cancer cells (Liang et al., 2017).